Showing results (121-130 of 197) with videos related to

Sort By:
Pageof 20
Molecular Cancer Therapeutics|June 16, 2005
Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitorJames G Christensen, Patrick W Vincent, Wayne D Klohs, et al.
Advances in Enzyme Regulation|January 1, 1989
Biochemical pharmacology and antitumor properties of 4-amino-8-[beta-D-ribofuranosylamino]pyrimido-[5,4-d]pyrimidineR C Jackson, T J Boritzki, P D Cook, et al.
Advances in Enzyme Regulation|January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activityR C Jackson, D W Fry, T J Boritzki, et al.
Investigational New Drugs|January 1, 1985
Dezaguanine mesylate: a new antipurine antimetaboliteW R Leopold, D W Fry, T J Boritzki, et al.
Journal of the National Cancer Institute|August 1, 1985
Collagen-production inhibitors evaluated as antitumor agentsW D Klohs, R W Steinkampf, M S Wicha, et al.
BMC Cancer|July 17, 2004
The influence of tumor size and environment on gene expression in commonly used human tumor linesMichael A Gieseg, Michael Z Man, Nicholas A Gorski, et al.
American Journal of Obstetrics and Gynecology|October 1, 1992
Second-trimester echogenic bowel and chromosomal abnormalitiesA L Scioscia, D H Pretorius, N E Budorick, et al.
Pediatric Nephrology (Berlin, Germany)|September 3, 2010
Intestinal damage in enterohemorrhagic Escherichia coli infectionZivile D Békássy, Carla Calderon Toledo, Gustav Leoj, et al.
Radiology|December 1, 1982
Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast materialR F Mattrey, F W Scheible, B B Gosink, et al.
Pageof 20